Evidence map›Paper›PMID 26487372›Full record

ReviewNutrition journal2015

IgY antibodies in human nutrition for disease prevention.

Sandra Müller, Andreas Schubert, Julia Zajac, Terry Dyck, Christopher Oelkrug

Open access · goldAbstract readReview
In one paragraph

Review in Nutrition journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Efficacy of IgY onAntibody therapeutics · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. IgY-mediated protection againstBioImpacts : BI · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sandra MüllerFraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstraße 1, 04103, Leipzig, Germany.
Andreas SchubertFraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstraße 1, 04103, Leipzig, Germany.
Julia ZajacFraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstraße 1, 04103, Leipzig, Germany.
Terry DyckIgY Immune Technologies and Life Sciences Inc., Thunder Bay, Canada.
Christopher OelkrugFraunhofer Institute for Cell Therapy and Immunology (IZI), Perlickstraße 1, 04103, Leipzig, Germany. christopher.oelkrug@izi.fraunhofer.de.
Fraunhofer Institute for Cell Therapy and Immunology · DEFraunhofer Society · DEMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral administration of preformed specific antibodies is an attractive approach against infections of the digestive system in humans and animals in times of increasing antibiotic resistances. Previous studies showed a positive effect of egg yolk IgY antibodies on bacterial intoxications in animals and humans. Immunization of chickens with specific antigens offers the possibility to create various forms of antibodies. Research shows that orally applied IgY's isolated from egg yolks can passively cure or prevent diseases of the digestive system. The use of these alternative therapeutic drugs provides further advantages: (1) The production of IgY's is a non-invasive alternative to current methods; (2) The keeping of chickens is inexpensive; (3) The animals are easy to handle; (4) It avoids repetitive bleeding of laboratory animals; (5) It is also very cost effective regarding the high IgY concentration within the egg yolk. Novel targets of these antigen specific antibodies are Helicobacter pylori and also molecules involved in signaling pathways in gastric cancer. Furthermore, also dental caries causing bacteria like Streptococcus mutans or opportunistic Pseudomonas aeruginosa in cystic fibrosis patients are possible targets. Therefore, IgY's included in food for human consumption may be able to prevent or cure human diseases.

Indexed as

AntibodiesDigestive System DiseasesEgg YolkHumansImmunoglobulinsAntibodiesIgYImmunoglobulins

Identifiers

PMID26487372
PMCPMC4617726
OpenAlexW2136647066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.